Cognitive Training for Psychosis
(E-SMART Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine how different types of cognitive training can help individuals with schizophrenia-spectrum disorders improve executive functioning, including skills like planning, problem-solving, and task management. Participants will be divided into three groups: one combining computer exercises with strategy development, one focusing solely on strategy development, and another on computer exercises only (referred to as Computerized Cognitive Training). The online format allows easy participation from home. Suitable candidates have a clinical diagnosis of a schizophrenia-related disorder, know how to use a computer, and are not struggling with substance abuse. As an unphased trial, this study offers a unique opportunity to contribute to research that may enhance cognitive therapies for schizophrenia-spectrum disorders.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that Executive Function Training is generally well-received by individuals with schizophrenia-related disorders. Previous studies have demonstrated that this training improves everyday skills like decision-making and problem-solving. No reports of serious side effects make it a safe choice for many.
For the Strategy Development approach, earlier research suggests that discussing new ways of thinking is both safe and effective. Participants usually find these discussions helpful and safe.
Several studies have tested Computerized Cognitive Training. It has improved skills like memory and attention in people with schizophrenia. This training is typically safe, with no major side effects reported. Studies indicate that participants can complete this training at home, offering a flexible option.
Overall, past studies have proven each of these training methods safe. They aim to improve thinking skills and have not been linked to serious risks.12345Why are researchers excited about this trial?
Researchers are excited about these cognitive training techniques for psychosis because they offer a fresh approach compared to traditional medication-based treatments. Unlike typical antipsychotics, which mainly target neurotransmitters, these methods focus on enhancing cognitive functions directly. The Executive Function Training combines computerized exercises and strategy development, providing a dual approach to boost mental skills. The Strategy Development method emphasizes practical cognitive strategies for everyday use, while the Computerized Cognitive Training focuses solely on enhancing cognitive performance through digital exercises. All of these interventions are delivered virtually, making them accessible and convenient for participants.
What evidence suggests that this trial's treatments could be effective for schizophrenia-spectrum disorders?
Research shows that Executive Function Training, one of the treatments in this trial, can improve thinking skills in people with psychosis. Studies have found that training focused on working memory can normalize cognitive patterns, potentially helping people with schizophrenia manage daily tasks better.
For the Strategy Development approach, another treatment arm in this trial, specific data is limited. However, creating cognitive strategies has been linked to better symptom control in psychotic disorders.
Computerized Cognitive Training, also studied in this trial, is well-supported. Research reviews show it significantly enhances thinking skills and daily functioning in people with schizophrenia. It also improves mental health and cognitive abilities through structured programs. Overall, each type of training in this trial offers promising ways to boost cognitive functioning in schizophrenia-related conditions.678910Who Is on the Research Team?
Michael Best, PhD
Principal Investigator
University of Toronto
Are You a Good Fit for This Trial?
This trial is for English-speaking adults aged 18-65 with a clinical diagnosis of schizophrenia, schizoaffective disorder, or another psychotic disorder. Participants should not be abusing drugs or alcohol and must know how to use a computer. It's not for those with physical handicaps, recent cognitive training, neurological diseases/damage, history of significant head injury, or illnesses affecting brain function.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo 4 weeks of group treatment with two 1-hour sessions per week, delivered virtually via Zoom
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Computerized Cognitive Training
- Executive Function Training
- Strategy Development
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Toronto
Lead Sponsor